PlainMeds drug rankings
Drugs with Most Hospitalization Reports
All tracked drugs ranked by FAERS reports involving hospitalization.
Data updated 2026-05-15
- 524
- Drugs ranked
- 203,341
- Top: Aspirin
- 45,226
- #50: Citalopram
In the Drugs with Most Hospitalization Reports ranking, Aspirin is #1 at 203,341 (Hospital Reports), out of 524 ranked drugs.
All tracked drugs ranked by FAERS reports involving hospitalization. Aspirin leads at 203,341, then Furosemide at 190,901. Every value is compiled live from official FDA and CMS records; see the methodology for how each figure is sourced and what it does and does not mean.
Verify with FDA → · CMS NADAC pricing →
What This Ranking Tells Us
Hospitalization reports in FAERS indicate cases where a drug-associated adverse event led to or extended a hospital stay. Widely prescribed medications naturally accumulate more reports. Blood thinners, insulin, and cardiovascular drugs often top this list because their therapeutic effects require careful dosing, too much or too little can require emergency intervention. These reports help FDA identify drugs that may benefit from improved dosing guidelines or additional monitoring requirements.
Top 12 by Hospital Reports
All tracked drugs ranked by FAERS reports involving hospitalization.
- aspirin
aspirin
203,341 Hospital Reports
- furosemide
furosemide
190,901 Hospital Reports
- prednisone
prednisone
166,315 Hospital Reports
- acetaminophen
acetaminophen
150,224 Hospital Reports
- adalimumab
adalimumab
146,638 Hospital Reports
- omeprazole
omeprazole
122,601 Hospital Reports
- metformin
metformin
122,330 Hospital Reports
- methotrexate
methotrexate
115,535 Hospital Reports
- pantoprazole
pantoprazole
111,504 Hospital Reports
- dexamethasone
dexamethasone
109,720 Hospital Reports
- amlodipine
amlodipine
104,040 Hospital Reports
- gabapentin
gabapentin
103,305 Hospital Reports
What this shows aspirin leads at 203,341, ahead of furosemide and prednisone.
The bar to make this list: a drug needs 45,226 hospital reports to rank in the top 50 of 524.
| # | Drug | Hospital Reports |
|---|---|---|
| 1 | aspirin | 203,341 |
| 2 | furosemide | 190,901 |
| 3 | prednisone | 166,315 |
| 4 | acetaminophen | 150,224 |
| 5 | adalimumab | 146,638 |
| 6 | omeprazole | 122,601 |
| 7 | metformin | 122,330 |
| 8 | methotrexate | 115,535 |
| 9 | pantoprazole | 111,504 |
| 10 | dexamethasone | 109,720 |
| 11 | amlodipine | 104,040 |
| 12 | gabapentin | 103,305 |
| 13 | rivaroxaban | 102,060 |
| 14 | ergocalciferol | 98,409 |
| 15 | metoprolol | 96,962 |
| 16 | lisinopril | 95,486 |
| 17 | simvastatin | 94,740 |
| 18 | clopidogrel | 88,784 |
| 19 | levothyroxine | 88,368 |
| 20 | folic acid | 87,188 |
| 21 | ibuprofen | 81,556 |
| 22 | prednisolone | 79,445 |
| 23 | pregabalin | 74,751 |
| 24 | allopurinol | 74,277 |
| 25 | lorazepam | 72,527 |
| 26 | atorvastatin | 68,513 |
| 27 | quetiapine | 67,436 |
| 28 | etanercept | 65,552 |
| 29 | alprazolam | 64,280 |
| 30 | spironolactone | 64,112 |
| 31 | ramipril | 62,948 |
| 32 | insulin glargine | 62,916 |
| 33 | lansoprazole | 62,821 |
| 34 | infliximab | 62,267 |
| 35 | rosuvastatin | 60,611 |
| 36 | warfarin | 57,230 |
| 37 | methylprednisolone | 53,959 |
| 38 | carvedilol | 53,070 |
| 39 | clozapine | 53,005 |
| 40 | oxycodone | 49,832 |
| 41 | losartan | 48,929 |
| 42 | hydrochlorothiazide | 48,508 |
| 43 | potassium chloride | 48,372 |
| 44 | levetiracetam | 47,411 |
| 45 | atenolol | 47,314 |
| 46 | ondansetron | 47,077 |
| 47 | clonazepam | 46,031 |
| 48 | olanzapine | 45,342 |
| 49 | zolpidem | 45,304 |
| 50 | citalopram | 45,226 |
Primary source: FDA Adverse Event Reporting System (FAERS). Supplementary labeling: FDA Drug Labels (SPL). These rankings are for informational purposes only and should not be used to make medical decisions.
Frequently Asked Questions
What does a hospitalization report in FAERS mean?
It means an adverse event report included hospitalization (initial or prolonged) as a serious outcome. The hospitalization may have been caused by the drug, an underlying condition, or a combination. FAERS does not determine causality, it documents associations for FDA to investigate.
Are drugs with more hospitalization reports less safe?
Not necessarily. Drugs prescribed to millions of people or to severely ill populations will naturally have more hospitalization reports. A per-prescription hospitalization rate would be more informative. These rankings are useful for identifying which drugs require the most post-marketing surveillance.
Reading the Drugs with Most Hospitalization Reports
This table ranks 50 drugs by hospital reports, sourced from FDA Adverse Event Reporting System (FAERS). The current leader is aspirin at 203,341, followed by furosemide and prednisone. Each row links to a full drug profile so readers can move from headline number to the underlying FDA data, labeling, FAERS reports, recalls, pricing, and shortage status, that explains why a particular drug sits where it does.
Hospitalization reports in FAERS indicate cases where a drug-associated adverse event led to or extended a hospital stay. Widely prescribed medications naturally accumulate more reports. Blood thinners, insulin, and cardiovascular drugs often top this list because their therapeutic effects require careful dosing, too much or too little can require emergency intervention. These reports help FDA identify drugs that may benefit from improved dosing guidelines or additional monitoring requirements.
Rankings are diagnostic, not prescriptive. Absolute numbers are shaped by exposure volume, reporting practices, and data-collection methodology, so a drug near the top is not automatically "worse" than a drug near the bottom, it may simply be older, more widely prescribed, or manufactured by firms with more visible reporting. Context from FDA Adverse Event Reporting System (FAERS) updates continuously, which means the relative order here can change from one refresh to the next. Rankings on this page are for educational research only and must not be used as a substitute for medical advice from a licensed clinician.
Explore More Rankings
Read our methodology - how this data is sourced, computed, and verified.
Source: FDA Adverse Event Reporting System (FAERS) FDA Adverse Event Reporting System (FAERS)
See our methodology for how this data is sourced, computed, and verified.
Data currency: FDA FAERS adverse-event reports through 2025, CMS NADAC acquisition-cost pricing effective December 2024, compiled and last refreshed May 2026. See our methodology for per-source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.